Biotricity Stock Market Value

BTCY Stock  USD 0.29  0.01  3.57%   
Biotricity's market value is the price at which a share of Biotricity trades on a public exchange. It measures the collective expectations of Biotricity investors about its performance. Biotricity is trading at 0.29 as of the 25th of January 2026; that is 3.57 percent increase since the beginning of the trading day. The stock's open price was 0.28.
With this module, you can estimate the performance of a buy and hold strategy of Biotricity and determine expected loss or profit from investing in Biotricity over a given investment horizon. Check out Biotricity Correlation, Biotricity Volatility and Biotricity Alpha and Beta module to complement your research on Biotricity.
For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.
Symbol

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biotricity. If investors know Biotricity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biotricity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.09)
Revenue Per Share
0.589
Quarterly Revenue Growth
0.21
Return On Assets
(0.11)
Return On Equity
(41.01)
The market value of Biotricity is measured differently than its book value, which is the value of Biotricity that is recorded on the company's balance sheet. Investors also form their own opinion of Biotricity's value that differs from its market value or its book value, called intrinsic value, which is Biotricity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biotricity's market value can be influenced by many factors that don't directly affect Biotricity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biotricity's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biotricity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biotricity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Biotricity 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biotricity's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biotricity.
0.00
10/27/2025
No Change 0.00  0.0 
In 2 months and 31 days
01/25/2026
0.00
If you would invest  0.00  in Biotricity on October 27, 2025 and sell it all today you would earn a total of 0.00 from holding Biotricity or generate 0.0% return on investment in Biotricity over 90 days. Biotricity is related to or competes with Aurora Spine, Guided Therapeutics, and Cell Source. Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United Sta... More

Biotricity Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biotricity's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biotricity upside and downside potential and time the market with a certain degree of confidence.

Biotricity Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Biotricity's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biotricity's standard deviation. In reality, there are many statistical measures that can use Biotricity historical prices to predict the future Biotricity's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Biotricity's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.010.296.74
Details
Intrinsic
Valuation
LowRealHigh
0.010.286.73
Details
Naive
Forecast
LowNextHigh
0.010.276.72
Details
1 Analysts
Consensus
LowTargetHigh
3.644.004.44
Details

Biotricity January 25, 2026 Technical Indicators

Biotricity Backtested Returns

Biotricity secures Sharpe Ratio (or Efficiency) of -0.17, which signifies that the company had a -0.17 % return per unit of risk over the last 3 months. Biotricity exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Biotricity's Standard Deviation of 7.1, risk adjusted performance of (0.09), and Mean Deviation of 5.35 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -1.01, which signifies a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Biotricity are expected to decrease slowly. On the other hand, during market turmoil, Biotricity is expected to outperform it slightly. At this point, Biotricity has a negative expected return of -1.11%. Please make sure to confirm Biotricity's jensen alpha, skewness, as well as the relationship between the Skewness and day typical price , to decide if Biotricity performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.52  

Modest predictability

Biotricity has modest predictability. Overlapping area represents the amount of predictability between Biotricity time series from 27th of October 2025 to 11th of December 2025 and 11th of December 2025 to 25th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biotricity price movement. The serial correlation of 0.52 indicates that about 52.0% of current Biotricity price fluctuation can be explain by its past prices.
Correlation Coefficient0.52
Spearman Rank Test0.53
Residual Average0.0
Price Variance0.0

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Biotricity Stock Analysis

When running Biotricity's price analysis, check to measure Biotricity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotricity is operating at the current time. Most of Biotricity's value examination focuses on studying past and present price action to predict the probability of Biotricity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotricity's price. Additionally, you may evaluate how the addition of Biotricity to your portfolios can decrease your overall portfolio volatility.